<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39340110</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Changes in Attitudes towards Influenza and Pneumococcal Vaccination during the Subsiding COVID-19 Pandemic-Results of a Longitudinal Survey Study among Risk Groups in Germany between 2021 and 2023.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1080</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12091080</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In many countries, an increase in influenza and pneumococcal vaccination rates was observed during the COVID-19 pandemic. We examined how attitude, risk perception and knowledge towards influenza and pneumococcal vaccines of at-risk patients developed when the COVID-19 pandemic subsided and if COVID-19 vaccination attitude (VA) was still associated with the attitudes towards the two other vaccines.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used longitudinal data from two surveys conducted in Germany in 2021 and 2023 among persons with chronic diseases. We assessed VA, risk perception, vaccination knowledge and further psychological determinants of vaccine acceptance. Structural equation modelling using full information maximum likelihood was used to estimate multivariate regressions with planned missing data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 543 respondents, the influenza and pneumococcal vaccination rates remained relatively stable between 2021 and 2023. VA also remained unchanged at a moderately positive level, while COVID-19 VA decreased. A constantly positive association between COVID-19 VA and influenza as well as pneumococcal VA was found, independent from a general VA. The perceived danger of influenza increased between 2021 and 2023 and was among the strongest predictors of influenza VA.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Also at the subsiding pandemic, COVID-19 VA was constantly associated with the influenza and pneumococcal VA. It seems sensible to take these aspects into account when designing future vaccination campaigns for at-risk patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">DRKS00024561. Registered 9 March 2021.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Born</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5803-7963</Identifier><AffiliationInfo><Affiliation>Institute of Infectious Diseases and Infection Control, Jena University Hospital, 07743 Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care, Jena University Hospital, 07743 Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarzkopf</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1568-8202</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, 07743 Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rose</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Infectious Diseases and Infection Control, Jena University Hospital, 07743 Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pletz</LastName><ForeName>Mathias W</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0001-8157-2753</Identifier><AffiliationInfo><Affiliation>Institute of Infectious Diseases and Infection Control, Jena University Hospital, 07743 Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care, Jena University Hospital, 07743 Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhart</LastName><ForeName>Konrad</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sepsis Foundation, 12203 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischmann-Struzek</LastName><ForeName>Carolin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Infectious Diseases and Infection Control, Jena University Hospital, 07743 Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care, Jena University Hospital, 07743 Jena, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>01VSF19020</GrantID><Agency>German Innovations Fund of the Federal Joint Committee</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">pneumococcal</Keyword><Keyword MajorTopicYN="N">risk perception</Keyword><Keyword MajorTopicYN="N">vaccination attitude</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340110</ArticleId><ArticleId IdType="pmc">PMC11435497</ArticleId><ArticleId IdType="doi">10.3390/vaccines12091080</ArticleId><ArticleId IdType="pii">vaccines12091080</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rose N., Storch J., Mikolajetz A., Lehmann T., Reinhart K., Pletz M.W., Forstner C., Vollmar H.C., Freytag A., Fleischmann-Struzek C. Preventive effects of influenza and pneumococcal vaccination in the elderly—Results from a population-based retrospective cohort study. Hum. Vaccines Immunother. 2021;17:1844–1852. doi: 10.1080/21645515.2020.1845525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1845525</ArticleId><ArticleId IdType="pmc">PMC8115600</ArticleId><ArticleId IdType="pubmed">33412080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa-Gondar O., Vila-Corcoles A., Rodriguez-Blanco T., Gomez-Bertomeu F., Figuerola-Massana E., Raga-Luria X., Hospital-Guardiola I. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged &gt;/= 60 years: 3 years of follow-up in the CAPAMIS study. Clin. Infect. Dis. 2014;58:909–917. doi: 10.1093/cid/ciu002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu002</ArticleId><ArticleId IdType="pubmed">24532544</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo C., Rezza G., Ricciardi W. Strategies in recommending influenza vaccination in Europe and US. Hum. Vaccines Immunother. 2018;14:693–698. doi: 10.1080/21645515.2017.1367463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2017.1367463</ArticleId><ArticleId IdType="pmc">PMC5861797</ArticleId><ArticleId IdType="pubmed">28922083</ArticleId></ArticleIdList></Reference><Reference><Citation>Perniciaro S., van der Linden M. Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study. Lancet Reg. Health–Eur. 2021;7:100126. doi: 10.1016/j.lanepe.2021.100126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100126</ArticleId><ArticleId IdType="pmc">PMC8454757</ArticleId><ArticleId IdType="pubmed">34557837</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprenger R., Hackl D., Kossack N., Schiffner-Rohe J., Wohlleben J., von Eiff C. Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time. PLoS ONE. 2022;17:e0265433. doi: 10.1371/journal.pone.0265433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265433</ArticleId><ArticleId IdType="pmc">PMC8939779</ArticleId><ArticleId IdType="pubmed">35316288</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Riccio M., Lina B., Caini S., Staadegaard L., Wiegersma S., Kynčl J., Combadière B., MacIntyre C.R., Paget J. Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia. Eurosurveillance. 2021;26:2101143. doi: 10.2807/1560-7917.ES.2021.26.50.2101143.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.50.2101143</ArticleId><ArticleId IdType="pmc">PMC8728488</ArticleId><ArticleId IdType="pubmed">34915972</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieck T., Steffen A., Feig M., Siedler A. Impfquoten bei Erwachsenen in Deutschland—Aktuelles aus der KV-Impfsurveillance. Epidemiol. Bull. 2021;50:3–22. doi: 10.25646/9436.</Citation><ArticleIdList><ArticleId IdType="doi">10.25646/9436</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda-García M.A., Hoffelner M., Stoll H., Ruhaltinger D., Cichutek K., Siedler A., Bekeredjian-Ding I. A 5-year look-back at the notification and management of vaccine supply shortages in Germany. Eurosurveillance. 2022;27:2100167. doi: 10.2807/1560-7917.ES.2022.27.17.2100167.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.17.2100167</ArticleId><ArticleId IdType="pmc">PMC9052770</ArticleId><ArticleId IdType="pubmed">35485267</ArticleId></ArticleIdList></Reference><Reference><Citation>Soveri A., Karlsson L.C., Antfolk J., Maki O., Karlsson L., Karlsson H., Nolvi S., Karukivi M., Lindfelt M., Lewandowsky S. Spillover effects of the COVID-19 pandemic on attitudes to influenza and childhood vaccines. BMC Public Health. 2023;23:764. doi: 10.1186/s12889-023-15653-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15653-4</ArticleId><ArticleId IdType="pmc">PMC10126550</ArticleId><ArticleId IdType="pubmed">37098527</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunz Trujillo K., Green J., Safarpour A., Lazer D., Lin J., Motta M. COVID-19 Spillover Effects onto General Vaccine Attitudes. Public Opin. Q. 2024;88:97–122. doi: 10.1093/poq/nfad059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/poq/nfad059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong G., Lim N.A., Chin Y.H., Ng Y.P.M., Amin Z. Effect of COVID-19 Pandemic on Influenza Vaccination Intention: A Meta-Analysis and Systematic Review. Vaccines. 2022;10:606. doi: 10.3390/vaccines10040606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10040606</ArticleId><ArticleId IdType="pmc">PMC9026798</ArticleId><ArticleId IdType="pubmed">35455354</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuchter R.K., Jackson N.J., Mafi J.N., Sarkisian C.A. Association between COVID-19 Vaccination and Influenza Vaccination Rates. N. Engl. J. Med. 2022;386:2531–2532. doi: 10.1056/NEJMc2204560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2204560</ArticleId><ArticleId IdType="pmc">PMC9258773</ArticleId><ArticleId IdType="pubmed">35704429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan C., Chen Y.C., Chang Y.I., Chuang P.C. Impact of COVID-19 Outbreak on Influenza and Pneumococcal Vaccination Uptake: A Multi-Center Retrospective Study. Vaccines. 2023;11:986. doi: 10.3390/vaccines11050986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11050986</ArticleId><ArticleId IdType="pmc">PMC10223787</ArticleId><ArticleId IdType="pubmed">37243090</ArticleId></ArticleIdList></Reference><Reference><Citation>Breuker C., Guedj A.M., Allan M., Coinus L., Molinari N., Chapet N., Roubille F., Le Quintrec M., Duhalde V., Jouglen J., et al. The COVID-19 Pandemic Led to a Small Increase in Changed Mentality Regarding Infection Risk without Any Change in Willingness to Be Vaccinated in Chronic Diseases Patients. J. Clin. Med. 2021;10:3967. doi: 10.3390/jcm10173967.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173967</ArticleId><ArticleId IdType="pmc">PMC8432078</ArticleId><ArticleId IdType="pubmed">34501415</ArticleId></ArticleIdList></Reference><Reference><Citation>Loubet P., Rouvière J., Merceron A., Launay O., Sotto A., on behalf of the AVNIR Group Patients’ Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections. Vaccines. 2021;9:1372. doi: 10.3390/vaccines9111372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9111372</ArticleId><ArticleId IdType="pmc">PMC8623007</ArticleId><ArticleId IdType="pubmed">34835303</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid P., Rauber D., Betsch C., Lidolt G., Denker M.L. Barriers of Influenza Vaccination Intention and Behavior—A Systematic Review of Influenza Vaccine Hesitancy, 2005–2016. PLoS ONE. 2017;12:e0170550. doi: 10.1371/journal.pone.0170550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0170550</ArticleId><ArticleId IdType="pmc">PMC5268454</ArticleId><ArticleId IdType="pubmed">28125629</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Minh Duc N.T., Luu Lam Thang T., Nam N.H., Ng S.J., Abbas K.S., Huy N.T., Marušić A., Paul C.L., Kwok J., et al. A Consensus-Based Checklist for Reporting of Survey Studies (CROSS) J. Gen. Intern. Med. 2021;36:3179–3187. doi: 10.1007/s11606-021-06737-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-06737-1</ArticleId><ArticleId IdType="pmc">PMC8481359</ArticleId><ArticleId IdType="pubmed">33886027</ArticleId></ArticleIdList></Reference><Reference><Citation>Askelson N.M., Campo S., Lowe J.B., Smith S., Dennis L.K., Andsager J. Using the theory of planned behavior to predict mothers’ intentions to vaccinate their daughters against HPV. J. Sch. Nurs. 2010;26:194–202. doi: 10.1177/1059840510366022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1059840510366022</ArticleId><ArticleId IdType="pubmed">20335232</ArticleId></ArticleIdList></Reference><Reference><Citation>Betsch C., Schmid P., Heinemeier D., Korn L., Holtmann C., Böhm R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE. 2018;13:e0208601. doi: 10.1371/journal.pone.0208601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208601</ArticleId><ArticleId IdType="pmc">PMC6285469</ArticleId><ArticleId IdType="pubmed">30532274</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer N.T., Chapman G.B., Gibbons F.X., Gerrard M., McCaul K.D., Weinstein N.D. Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination. Health Psychol. 2007;26:136–145. doi: 10.1037/0278-6133.26.2.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0278-6133.26.2.136</ArticleId><ArticleId IdType="pubmed">17385964</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D., Story D., Clavisi O., Jones R., Peyton P. An Introductory Guide to Survey Research in Anaesthesia. Anaesth. Intensive Care. 2006;34:245–253. doi: 10.1177/0310057X0603400219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X0603400219</ArticleId><ArticleId IdType="pubmed">16617649</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns K.E.A., Duffett M., Kho M.E., Meade M.O., Adhikari N.K.J., Sinuff T., Cook D.J. A guide for the design and conduct of self-administered surveys of clinicians. Can. Med. Assoc. J. 2008;179:245–252. doi: 10.1503/cmaj.080372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.080372</ArticleId><ArticleId IdType="pmc">PMC2474876</ArticleId><ArticleId IdType="pubmed">18663204</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagida T. misty: Miscellaneous Functions ‘T. Yanagida’. 2022.  [(accessed on 18 September 2024)].  Available online:  https://CRAN.R-project.org/package=misty.</Citation></Reference><Reference><Citation>Raykov T. Estimation of Composite Reliability for Congeneric Measures. Appl. Psychol. Meas. 1997;21:173–184. doi: 10.1177/01466216970212006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01466216970212006</ArticleId></ArticleIdList></Reference><Reference><Citation>Oehlert G.W. A Note on the Delta Method. Am. Stat. 1992;46:27–29. doi: 10.1080/00031305.1992.10475842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00031305.1992.10475842</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham J.W., Taylor B.J., Olchowski A.E., Cumsille P.E. Planned missing data designs in psychological research. Psychol. Methods. 2006;11:323–343. doi: 10.1037/1082-989X.11.4.323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1082-989X.11.4.323</ArticleId><ArticleId IdType="pubmed">17154750</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhemtulla M., Hancock G.R. Planned missing data designs in educational psychology research. Educ. Psychol. 2016;51:305–316. doi: 10.1080/00461520.2016.1208094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00461520.2016.1208094</ArticleId></ArticleIdList></Reference><Reference><Citation>Enders C.K. Analyzing structural equation models with missing data. Struct. Equ. Model. Second Course. 2006;2:493–519.</Citation></Reference><Reference><Citation>Enders C.K. The performance of the full information maximum likelihood estimator in multiple regression models with missing data. Educ. Psychol. Meas. 2001;61:713–740. doi: 10.1177/0013164401615001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0013164401615001</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2023.</Citation></Reference><Reference><Citation>Rosseel Y. lavaan: An R Package for Structural Equation Modeling. J. Stat. Softw. 2012;48:1–36. doi: 10.18637/jss.v048.i02.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v048.i02</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwetkat A., Heppner H.J., Endre A.S., Leischker A.H. Current recommendations for vaccination in older adults. MMW Fortschr. Med. 2021;163:42–49. doi: 10.1007/s15006-021-9851-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15006-021-9851-5</ArticleId><ArticleId IdType="pmc">PMC8146179</ArticleId><ArticleId IdType="pubmed">34033047</ArticleId></ArticleIdList></Reference><Reference><Citation>Achterbergh R.C.A., McGovern I., Haag M. Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023. Vaccines. 2024;12:216. doi: 10.3390/vaccines12020216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12020216</ArticleId><ArticleId IdType="pmc">PMC10891656</ArticleId><ArticleId IdType="pubmed">38400199</ArticleId></ArticleIdList></Reference><Reference><Citation>Skyles T.J., Stevens H.P., Obray A.M., Jensen J.L., Miner D.S., Bodily R.J., Nielson B.U., Poole B.D. Changes in Attitudes and Barriers to Seasonal Influenza Vaccination from 2007 to 2023. J. Community Health. 2024;49:207–217. doi: 10.1007/s10900-023-01277-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10900-023-01277-7</ArticleId><ArticleId IdType="pubmed">37697225</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Liu X., Yan D., Zhou Y., Ding C., Chen L., Lan L., Huang C., Jiang D., Zhang X., et al. Global influenza vaccination rates and factors associated with influenza vaccination. Int. J. Infect. Dis. 2022;125:153–163. doi: 10.1016/j.ijid.2022.10.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.10.038</ArticleId><ArticleId IdType="pubmed">36328290</ArticleId></ArticleIdList></Reference><Reference><Citation>Du P., Jin S., Lu S., Wang L., Ma X., Wang J., Huang R., Luo Q., Yang S., Feng X. Strategies to increase the coverage of influenza and pneumonia vaccination in older adults: A systematic review and network meta-analysis. Age Ageing. 2024;53:afae035. doi: 10.1093/ageing/afae035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afae035</ArticleId><ArticleId IdType="pubmed">38476102</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillard J.P., Shen L. Pro-Vaccination Flu and COVID-19 Messages: Evidence of Congenial Targeted and Spillover Effects. COVID. 2024;4:363–377. doi: 10.3390/covid4030024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid4030024</ArticleId></ArticleIdList></Reference><Reference><Citation>Domnich A., Grassi R., Fallani E., Ciccone R., Bruzzone B., Panatto D., Ferrari A., Salvatore M., Cambiaggi M., Vasco A., et al. Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey. J. Pers. Med. 2022;12:139. doi: 10.3390/jpm12020139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12020139</ArticleId><ArticleId IdType="pmc">PMC8878648</ArticleId><ArticleId IdType="pubmed">35207628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>